The US regulator has approved the first non-injectable emergency medicine for diabetics who suffer potentially fatal low blood sugar levels. Eli Lilly’s intranasal formulation of glucagon ...
The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as ... priced at a similar level to the glucagon injection kits available on the market, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback